期刊文献+

组蛋白乙酰化、甲基化调控异常在弥漫性大B细胞淋巴瘤中的意义 被引量:3

Study on irregulatory modification of histone acetylation, methylation in diffuse large B-cell lymphoma
原文传递
导出
摘要 目的研究组蛋白H3(H3K9、H3K14)、H4(H4K5、H4K8、H4K12、H4K16)乙酰化、组蛋白H3K4、H3K9甲基化水平在弥漫性大B细胞淋巴瘤(DLBCL)细胞的表达意义及其相关性。方法采用免疫组织化学sP法检测40例DLBCL,16例增生性淋巴结炎组织细胞中组蛋白H3、H4乙酰化水平、组蛋白H3K4、H3K9甲基化水平并进行分析和比较。结果在DLBCL组中,乙酰化组蛋白H3、H4和甲基化组蛋白H3K4阳性高表达显著低于增生性淋巴结炎组;而甲基化组蛋白H3K9的阳性高表达则显著高于增生性淋巴结炎组(P〈0.05),差异均有统计学意义。在DLBCL组,乙酰化组蛋白H3与乙酰化组蛋白H4、乙酰化组蛋白H3与甲基化组蛋白H3K4、乙酰化组蛋白H4与甲基化组蛋白H3K4的表达均有显著的相关性(P〈0.01)。结论DLBCL存在组蛋白乙酰化及甲基化调控异常,可能是致病的重要因素之一。 Objective To investigate the expression of histone acetylated H3 and H4, methylated H3K4 and H3K9 in diffuse large B-cell lymphoma (DLBCL). Methods The expression of histone aeetylated H3 and H4, methylated H3K4 and H3K9 were examined by SP immunohistochemistry technique in lymphoid tissue of 40 cases with DLBCL and 16 cases with proliferative lymphadenitis. Results The expression of histone acetylation of H3 and H4 were lower than that in proliferative lymphadenitis. Histone methylated H3K4 was lower in expression and H3K9 was in higher expression. There was a positive correlative expression between the global histone acetylation of H3 and H4, the global histone acetylation of H3, H4 and histone methylation of H3K4. Conclusion Improper modification of histone aeetylations and methylations may play an important role in pathogenesis in DLBCL.
出处 《白血病.淋巴瘤》 CAS 2009年第10期599-602,共4页 Journal of Leukemia & Lymphoma
基金 基金项目:卫生部科学研究基金福建卫生教育联合攻关计划(wkj2008-2-55) 漳州市2007年科技计划(Z07014) 福建医科大学科研发展专项基金(FZS08018)
关键词 淋巴瘤 大细胞 弥漫性 组蛋白类 甲基化 乙酰化 Lymphoma, large cell, diffuse Histone Methylation Acetylation
  • 相关文献

参考文献19

  • 1Lyko F, Brow R. DNA methyltransferase inhibitiors and the development of epigenetic cancer therapies. J Nail Cancer Ivst, 2005, 97: 1498-1506.
  • 2Geiman TM, Robertson KD. Chromatin remodeling, histone modifications,and DNA methylation-how does it all fit together? J Cell Biochem, 2002, 87: 117-125.
  • 3Minucci S, Nervi C, Lo Coco F, et al. Histone deacetylases: a common molecular target for differentiation treatment myeloid leukemias. Oncogene, 2001, 20:3110-3115.
  • 4Yamaguchi Y, Kurokawa M, Imai Y, et al. AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues. J Biol Chem, 2004, 279: 15630-15638.
  • 5Davis JN, McGhee L, Meyers S. The ETO (MTG8) gene family. Gene, 2003, 303: 1-10.
  • 6Hildebrand D, Tiefenbach J, Heinzel T, et al. Multiple regions of ETO cooperate in transcriptional repression. J Bio Chem, 2001, 276: 9889-9895.
  • 7Durst KL, Lutterbach B, Kummalue T, et al. The inv(16) fusion protein associates with coexpressors via a smooth muscle myosin heavy-chain domain. Mol Cel Bio, 2003, 23: 607-619.
  • 8Ma XD, Fang YQ, Beklemisheva A, et al. Phenyhexyle isothiocyanate inhibits histone de.acetylase and remodels chromation to induce growth arrest in human leukemia cells. Inter J Oncol, 2006, 28: 1287-1294.
  • 9黄轶群,马旭东,郑瑞玑,CHIAO Jen-wei,LIU De-long.异硫氰酸苯己酯对Molt-4细胞组蛋白甲基化、乙酰化调控的实验研究[J].中华血液学杂志,2007,28(9):612-615. 被引量:16
  • 10Bryant H, Farrell PJ. Signal transduction and transcription factor modification during reactivation of epstein-barr virus from latency. J Virol, 2002, 76: 10290-10298.

二级参考文献11

  • 1Xiao D, Sfivastava SK, Lew KL, et al. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carci nogenesis, 2003,24 : 891-897.
  • 2Ma X, Fang Y, Beklemisheva A, et al. Phenyhexyle isothiocyanate inhibits histone deacetylase and remodels chromation to induce growth arrest in human leukemia cells. Int J Oncol,2006,28:1287-1293.
  • 3Jenuwein T, Allis CD. Translating the histone code. Science,2001, 293 : 1074-1080.
  • 4Nakayama J, Rice JC, Strahl BD, et al. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science, 2001,292: 110-113.
  • 5Bird A. Methylation talk between histone and DNA. Science,2001, 294:2113-2115.
  • 6Cheung P, Lau P. Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol,2005 ,19 :563-573.
  • 7Zegerman P, Canas B, Pappin D, et al. Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem, 2002,277 : 11621-11624.
  • 8Kondo Y, Shen L, Issa JP. Critical role of histone methylation in tumorsuppressor gene silencing in colorectal cancer. Mol Cell Biol, 2003,23:206-215.
  • 9Spotswood HT, Turner BM. An increasingly complex code. J Clin Invest, 2002,110:577-582.
  • 10Minucci S, Nervi C, Lo Coco F, et al. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? Oncogene ,2001,20:3110-3115.

共引文献15

同被引文献35

  • 1Ma X, Fang Y, Beklemisheva A, et al. Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells, Int J Oncol, 2006; 28(5) : 1287 -1293.
  • 2Herman JG, Graft JR, Myohanen, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996; 93(18) : 9821 -9826.
  • 3Spotswood HT, Tumer BM. An increasingly complex code. J Clin Invest, 2002 ; 110 ( 5 ) : R577 - R582.
  • 4Peterson CL, Laniel M. Histones and histone modifications. Curr Biol, 2004, 14(14) : 546 -551.
  • 5Jenuwein T. The epigenefic magic of histone lysine methylation. FEBS J, 2006; 273(14) : 3121 -3135.
  • 6Nakayama J, Rice JC, Strahl BD, et al. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science, 2001 ;292(5514) : 110 - 113.
  • 7Ogawa M, Sakashita K, Zhao XY, et al. Analysis of histone modification around the CpG island region of the p15 gene in acute myeloblastic leukemia. Leuk Res, 2007 ;31 (4) :611 - 621.
  • 8Tischoff I, Wittekind C, Tannapfel A. Role of epigenetic alterations in cholangiocarcinoma. J Hepatobiliary Pancreat Surg, 2006;13(4) : 274 -279.
  • 9Kondo Y, Shen L, Issa J P. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol,2003 ;23( 1 ) :206 -215.
  • 10Rush L J, Plass C. Alterations of DNA methylation in hematologic malignancies. Cancer Lett, 2002; 185( 1 ) : 1 - 12.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部